Potassium Chloride Capsule, Extended Release
FDA Label NDC 0904-7543

25 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Potassium Chloride (NDC 0904-7543). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 administration and monitoring, 2.2 adult dosing, 2.3 pediatric dosing, 3 dosage forms and strengths, 4 contraindications, 5.1 gastrointestinal adverse reactions, 6 adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7543-61

Unit Dose

Potassium Chloride

Extended-Release

Capsules, USP

[750 mg] 10 mEq K

100 CAPSULES (10 x 10)

Rx only

10meq K Carton Label (B958e083 0d67 4dd8 B52b 9dfe560dc1ba 00)

10meq K Carton Label (B958e083 0d67 4dd8 B52b 9dfe560dc1ba 00)

* Please review the disclaimer below.